Quintiles

Frederic “Rick” Sax has been named senior vice president and global head of the Integrated Clinical Services division at Quintiles. He is responsible for the business lines that comprise Integrated Clinical Services, including Central Laboratory, Cardiac Safety, Biostatistics, Regulatory Affairs, Medical Writing and Lifecycle Safety Services.

“Rick’s deep and broad experience in biopharma gives him a solid understanding of the challenges that our customers face in the New Health,” said Paula Brown Stafford, president of Quintiles Clinical Development. “He will help our customers navigate challenges and seize opportunities through the delivery of integrated clinical trial services that help customers reduce overall study costs, proactively manage quality, simplify trial management and accelerate development.”

Dr. Sax has nearly 20 years of experience in the biopharmaceutical industry. Most recently he served as vice president of Clinical Design Strategies for AstraZeneca, leading the design of solutions to enhance the quality of program and trial design while driving efficiencies in cost, time and process. He has held executive-level positions at both AstraZeneca and Merck Research Laboratories, where he managed the successful development and registration of new therapies. Prior to joining the biopharmaceutical industry, Dr. Sax served as an academic cardiologist.